With the analysis among 1,586 patents, we discovered top 444 key players by total patent application. Celularity, Inc., Anthrogenesis Corp., Shandong Qilu Stem Cells Engineering Co. Ltd. are dominant in this area. They take 13.93% of the total patent filing.
New Jersey, United States
Patent: 114
New Jersey, United States
Patent: 80
Shandong Qilu Stem Cells Engineering Co. Ltd.
Shandong Sheng, China
Patent: 27
Cryo-Cell International, Inc.
The General Hospital Corp.
Massachusetts, United States
Patent: 21
California, United States
Patent: 21
Nordrhein-Westfalen, Germany
Patent: 21
New Jersey, United States
Patent: 20
Gyeonggi-do, South Korea
Patent: 19
With the analysis among 39 patents, we discovered top 13 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Cellenkos, Inc., Stemmed are active in this area.
Institut National de la Santé et de la Recherche Médicale
Texas, United States
Patent: 9
Georgia, United States
Patent: 5
California, United States
Patent: 2
Minnesota, United States
Patent: 2
California, United States
Patent: 1
Cytoimmune Therapeutics, Inc.
California, United States
Patent: 1
Deverra Therapeutics, Inc.
Washington, United States
Patent: 1
With the analysis among related 885 patents applied in the last 5 years. We discover 350 most active companies in this area. The fast-growing Celularity, Inc., Duke University, Shandong Qilu Stem Cells Engineering Co. Ltd. take 10.17% of patent filing during this period.
New Jersey, United States
Patent: 46
North Carolina, United States
Patent: 22
Shandong Qilu Stem Cells Engineering Co. Ltd.
Shandong Sheng, China
Patent: 22
California, United States
Patent: 21
The Abraham J. & Phyllis Katz Cord Blood Foundation
Ohio, United States
Patent: 16
Sorrento Therapeutics, Inc.
California, United States
Patent: 14
Liaoning Heze Biological Technology Co., Ltd.
Liaoning Sheng, China
Patent: 13
The Board of Regents of The University of Texas System
Texas, United States
Patent: 13
Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd.
Guangdong Sheng, China
Patent: 11
With the analysis among related 885 patents in last 5 years, we discover 278 new entrants. NantCell, Inc., The Abraham J. & Phyllis Katz Cord Blood Foundation, Sorrento Therapeutics, Inc. are the most active new entrants in this area.
California, United States
Patent: 21
The Abraham J. & Phyllis Katz Cord Blood Foundation
Ohio, United States
Patent: 16
Sorrento Therapeutics, Inc.
California, United States
Patent: 14
Inner Mongolia Yinhong Stem Cell Technology Investment Co.
Nei Mongol Zizhiqu, China
Patent: 9
Texas, United States
Patent: 9
California, United States
Patent: 8
Regrow Biosciences Pvt Ltd.
Maharashtra, India
Patent: 7
Newish Technology (Beijing) Co., Ltd.
Beijing Shi, China
Patent: 7
Primoris Therapeutics Co., Ltd.
Therapeutic Solutions International, Inc.
California, United States
Patent: 5
With the analysis among 481 patents, we discovered top 68 universities and scientific research institutions by total patent application. Duke University, Rutgers State University of New Jersey, University of South Florida are dominant in this area. They take 16.01% of the total patent filing.
North Carolina, United States
Patent: 24
Rutgers State University of New Jersey
New Mexico, United States
Patent: 21
University of South Florida
The Johns Hopkins University
The Salk Institute for Biological Studies
California, United States
Patent: 11
National University of Singapore
Central Region, Singapore
Patent: 9
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 9
The Scripps Research Institute
California, United States
Patent: 8
Case Western Reserve University
Ohio, United States
Patent: 7